Search Results for cannabis

Showing 1 – 6

FDA Warns Four Companies Selling Cannabidiol Over Unproven Claims By Michael Mezher - Published 01 November 2017

The US Food and Drug Administration (FDA) on Wednesday warned four companies selling cannabidiol (CBD) containing products for making claims that their products can treat or cure cancer and other diseases, including Alzheimer's, arthritis, heart disease and stroke.

Categories: News, US, FDA

Tags: Cannabidiol, Marijuana, Cannabis, Cannabinoids, Warning Letter

FDA Considers WHO Scheduling Change for 17 Drug Substances By Zachary Brennan - Published 11 August 2017

The US Food and Drug Administration (FDA) on Friday sought public comments to help prepare a response to the World Health Organization (WHO) regarding the abuse liability and diversion of 17 drug substances, many of which are opioids and similar to fentanyl. WHO will consider whether to recommend certain international restrictions be placed on the drugs.

Categories: News, US, FDA, WHO, Crisis management, Drugs, Government affairs

Tags: drug substances, fentanyl, opioids, cannabis

FDA Seeks Comment on WHO Recommendations Restricting Certain Psychotropic Substances By Zachary Brennan - Published 10 January 2017

The Food and Drug Administration (FDA) on Tuesday offered a chance for those interested to submit written comments or request an informal public meeting on recommendations by the World Health Organization (WHO) to impose international manufacturing and distributing restrictions on certain drug substances.

Categories: News, US, FDA, WHO, Drugs, Government affairs, Product withdrawl and retirement

Tags: cannabis, marijuana, controlled substances, DEA

Asia Regulatory Roundup: India Begins Reviewing Drug Recall Guidelines (29 November 2016) By Nick Paul Taylor - Published 29 November 2016

Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.

Categories: News, Asia, CDSCO, CFDA, TGA, Biologics and biotechnology, Drugs, Government affairs, Manufacturing, Medical Devices, Regulatory intelligence, Regulatory strategy

Tags: drug recalls, medicinal cannabis, antidiabetic

FOIA'd Documents Show FDA's Rationale Against Marijuana Rescheduling By Michael Mezher - Published 19 October 2016

In a report and other documents obtained by Vice News via the Freedom of Information Act (FOIA), the US Food and Drug Administration (FDA) lays out its case against rescheduling marijuana.

Categories: News, US, FDA, Drugs, Government affairs

Tags: Marijuana, Medical Marijuana, Schedule 1, Drug Enforcement Administration, Cannabis, Cannabinoid, Marinol

UK’s MHRA: Products Containing Cannabis Extract are Medicines By Zachary Brennan - Published 12 October 2016

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has recently come to the decision that products containing cannabidiol (CBD) are medicines, following a regulatory review of such products.

Categories: News, Europe, MHRA, Compliance, Drugs, Government affairs, Regulatory intelligence, Regulatory strategy

Tags: CBD, cannabis, marijuana, Cannabidiol, cannabinoids